Strategic Role of Packaging, Safety and
Risk Management in Pharmaceutical
Marketing
Presented BY
1. M. Faisal 5051321097
2. M. Aqib Aslam 5051321075
3. Aamir Yaqoob 5051321089
4. Areez Akhtar 5051321058
5. Waqas Ahmed 5051321087
6. Dilawar Hussain 5051321061
7. M. Usama 5051321094
8. M. Ayub 5051321076
Presented TO
Ms. Maria Altaf
Faculty of Pharmacy
IBADAT International University, Islamabad
.
Introduction
 Pharmaceutical marketing focuses on delivering value with trust.
 Medicines directly affect human health, so quality and safety are
critical.
 Marketing success depends on:
 Product reliability
 Patient confidence
 Regulatory compliance
 Packaging, safety, and risk management are core supporting pillars.
Importance of this Topic
 Medicines are not ordinary consumer products.
 Doctors and patients evaluate:
 Safety profile
 Quality assurance
 Manufacturer credibility
 Poor packaging or safety failure leads to:
 Loss of brand trust
 Market withdrawal
 Legal consequences
Strategic Marketing in the
Pharmaceutical Industry
 Pharmaceutical marketing is strategy-driven, not only promotion.
 Strategy includes:
 Product design
 Packaging decisions
 Risk prevention mechanisms
 Objective: Long-term brand sustainability.
Relationship Between Operations &
Marketing
 Operational activities directly affect marketing performance.
 Examples:
 Packaging defect → product recall → brand damage
 Safety incident → negative corporate image
 Risk management protects:
 Brand equity
 Market continuity
 Customer loyalty
Scope of the Presentation
 Pharmaceutical Packaging & Labeling Management.
 Safety, Health & Environmental Management.
 Risk Management in Pharmaceutical Production.
 Focus on strategic impact on pharmaceutical marketing.
Pharmaceutical Packaging as a
Marketing Tool
 Packaging is a non-verbal marketing communication.
 It conveys:
 Product quality
 Safety assurance
 Brand professionalism
 Well-designed packaging increases:
 Brand recognition
 Market acceptance
Primary Packaging
 Direct contact with pharmaceutical product.
 Examples:
 Blister packs
 Bottles
 Ampoules
 Marketing importance:
 Patient convenience
 Product integrity
 Improved adherence
Secondary Packaging
 Outer protective and informative packaging.
 Includes:
 Cartons
 Package inserts
 Marketing role:
 Branding and product identity
 Communication of essential information
Tertiary Packaging
 Used for bulk handling and transportation.
 Protects products during:
 Storage
 Distribution
 Marketing value:
 Cost efficiency
 Market availability
 Reduced supply disruptions
Packaging and Patient Compliance
 Easy-to-open and unit-dose packaging.
 Improves:
 Correct dosing
 Treatment adherence
 Compliance leads to:
 Better therapeutic outcomes
 Brand loyalty
Packaging as a Competitive Advantage
 Differentiation in crowded markets.
 Attractive design improves:
 Shelf visibility
 Brand recall
 Supports competitive marketing strategies.
Packaging Strategy and Target Market
 Premium brands use advanced packaging.
 Generic medicines focus on affordability.
 Packaging decisions support:
 Market segmentation
 Pricing strategy
Blister Packaging
 Individual dose protection system.
 Advantages:
 Product stability
 Reduced contamination
 Marketing relevance:
 Preferred in chronic therapy
 Perceived as high-quality packaging
Bottling
 Common for tablets, capsules, and syrups.
 Advantages:
 Convenience for bulk use
 Brand labeling space
 Marketing relevance:
 Suitable for mass markets
Strip Packaging
 Cost-effective packaging method.
 Widely used in developing countries.
 Marketing relevance:
 Affordable pricing
 Wide patient reach
Regulatory-Compliant Labeling
 Mandatory under drug laws.
 Includes:
 Drug name and strength
 Directions and warnings
 Ensures:
 Legal market entry
 Consumer trust
Labeling as Marketing
Communication
 Label is the first physical interaction.
 Clear labeling:
 Builds credibility
 Reduces medication errors
 Supports ethical pharmaceutical marketing.
Anti-Counterfeit Technologies
 Counterfeit medicines threaten public health.
 Common technologies:
 QR codes
 Holograms
 Serialization
 Protects brand authenticity.
Marketing Importance of Anti-
Counterfeiting
 Ensures product originality.
 Increases:
 Doctor confidence
 Patient trust
 Maintains long-term market share.
Safety, Health & Environmental
Management
 Integral part of pharmaceutical operations.
 Demonstrates corporate responsibility.
 Strong safety culture enhances brand reputation.
Occupational Health & Safety
 Protects workforce from hazards.
 Prevents accidents and downtime.
 Marketing benefit:
 Ethical company image
 Investor and stakeholder confidence
Hazardous Waste Management
 Safe disposal of chemical and pharma waste.
 Prevents environmental contamination.
 Improves corporate credibility.
Environmental Monitoring
 Monitoring air, water, and waste.
 Ensures compliance with regulations.
 Eco-friendly practices strengthen brand image.
Fire Safety & Toxic Chemical
Handling
 Prevents disasters and production loss.
 Ensures uninterrupted supply.
 Protects company reputation in the market.
Risk Management in Pharmaceutical
Production
 Systematic identification and control of risks.
 Ensures product quality and consistency.
 Critical for market sustainability.
Risk Assessment Tools
 FMEA:
 Identifies failure points
 HAZOP:
 Analyzes operational hazards
 Prevents costly recalls and shortages.
Supply Chain Risks
 Raw material shortages.
 Transportation delays.
 Affects market availability.
Production Failure Risks
 Equipment malfunction.
 Quality defects.
 Leads to recalls and brand damage.
Business Continuity Planning
 Emergency preparedness strategies.
 Backup suppliers and facilities.
 Ensures uninterrupted market supply
Integrated Marketing Impact
 Packaging + Safety + Risk management.
 Builds trust and loyalty.
 Strengthens competitive position.
Conclusion
 Strategic management supports marketing success.
 Protects brand image.
 Ensures sustainable pharmaceutical growth.
Pharmaceutical Packaging and Hazardous in Industry.pptx

Pharmaceutical Packaging and Hazardous in Industry.pptx

  • 1.
    Strategic Role ofPackaging, Safety and Risk Management in Pharmaceutical Marketing
  • 2.
    Presented BY 1. M.Faisal 5051321097 2. M. Aqib Aslam 5051321075 3. Aamir Yaqoob 5051321089 4. Areez Akhtar 5051321058 5. Waqas Ahmed 5051321087 6. Dilawar Hussain 5051321061 7. M. Usama 5051321094 8. M. Ayub 5051321076 Presented TO Ms. Maria Altaf Faculty of Pharmacy IBADAT International University, Islamabad .
  • 3.
    Introduction  Pharmaceutical marketingfocuses on delivering value with trust.  Medicines directly affect human health, so quality and safety are critical.  Marketing success depends on:  Product reliability  Patient confidence  Regulatory compliance  Packaging, safety, and risk management are core supporting pillars.
  • 4.
    Importance of thisTopic  Medicines are not ordinary consumer products.  Doctors and patients evaluate:  Safety profile  Quality assurance  Manufacturer credibility  Poor packaging or safety failure leads to:  Loss of brand trust  Market withdrawal  Legal consequences
  • 5.
    Strategic Marketing inthe Pharmaceutical Industry  Pharmaceutical marketing is strategy-driven, not only promotion.  Strategy includes:  Product design  Packaging decisions  Risk prevention mechanisms  Objective: Long-term brand sustainability.
  • 6.
    Relationship Between Operations& Marketing  Operational activities directly affect marketing performance.  Examples:  Packaging defect → product recall → brand damage  Safety incident → negative corporate image  Risk management protects:  Brand equity  Market continuity  Customer loyalty
  • 7.
    Scope of thePresentation  Pharmaceutical Packaging & Labeling Management.  Safety, Health & Environmental Management.  Risk Management in Pharmaceutical Production.  Focus on strategic impact on pharmaceutical marketing.
  • 8.
    Pharmaceutical Packaging asa Marketing Tool  Packaging is a non-verbal marketing communication.  It conveys:  Product quality  Safety assurance  Brand professionalism  Well-designed packaging increases:  Brand recognition  Market acceptance
  • 9.
    Primary Packaging  Directcontact with pharmaceutical product.  Examples:  Blister packs  Bottles  Ampoules  Marketing importance:  Patient convenience  Product integrity  Improved adherence
  • 10.
    Secondary Packaging  Outerprotective and informative packaging.  Includes:  Cartons  Package inserts  Marketing role:  Branding and product identity  Communication of essential information
  • 11.
    Tertiary Packaging  Usedfor bulk handling and transportation.  Protects products during:  Storage  Distribution  Marketing value:  Cost efficiency  Market availability  Reduced supply disruptions
  • 13.
    Packaging and PatientCompliance  Easy-to-open and unit-dose packaging.  Improves:  Correct dosing  Treatment adherence  Compliance leads to:  Better therapeutic outcomes  Brand loyalty
  • 14.
    Packaging as aCompetitive Advantage  Differentiation in crowded markets.  Attractive design improves:  Shelf visibility  Brand recall  Supports competitive marketing strategies.
  • 15.
    Packaging Strategy andTarget Market  Premium brands use advanced packaging.  Generic medicines focus on affordability.  Packaging decisions support:  Market segmentation  Pricing strategy
  • 16.
    Blister Packaging  Individualdose protection system.  Advantages:  Product stability  Reduced contamination  Marketing relevance:  Preferred in chronic therapy  Perceived as high-quality packaging
  • 17.
    Bottling  Common fortablets, capsules, and syrups.  Advantages:  Convenience for bulk use  Brand labeling space  Marketing relevance:  Suitable for mass markets
  • 18.
    Strip Packaging  Cost-effectivepackaging method.  Widely used in developing countries.  Marketing relevance:  Affordable pricing  Wide patient reach
  • 19.
    Regulatory-Compliant Labeling  Mandatoryunder drug laws.  Includes:  Drug name and strength  Directions and warnings  Ensures:  Legal market entry  Consumer trust
  • 20.
    Labeling as Marketing Communication Label is the first physical interaction.  Clear labeling:  Builds credibility  Reduces medication errors  Supports ethical pharmaceutical marketing.
  • 21.
    Anti-Counterfeit Technologies  Counterfeitmedicines threaten public health.  Common technologies:  QR codes  Holograms  Serialization  Protects brand authenticity.
  • 22.
    Marketing Importance ofAnti- Counterfeiting  Ensures product originality.  Increases:  Doctor confidence  Patient trust  Maintains long-term market share.
  • 23.
    Safety, Health &Environmental Management  Integral part of pharmaceutical operations.  Demonstrates corporate responsibility.  Strong safety culture enhances brand reputation.
  • 24.
    Occupational Health &Safety  Protects workforce from hazards.  Prevents accidents and downtime.  Marketing benefit:  Ethical company image  Investor and stakeholder confidence
  • 25.
    Hazardous Waste Management Safe disposal of chemical and pharma waste.  Prevents environmental contamination.  Improves corporate credibility.
  • 26.
    Environmental Monitoring  Monitoringair, water, and waste.  Ensures compliance with regulations.  Eco-friendly practices strengthen brand image.
  • 27.
    Fire Safety &Toxic Chemical Handling  Prevents disasters and production loss.  Ensures uninterrupted supply.  Protects company reputation in the market.
  • 28.
    Risk Management inPharmaceutical Production  Systematic identification and control of risks.  Ensures product quality and consistency.  Critical for market sustainability.
  • 29.
    Risk Assessment Tools FMEA:  Identifies failure points  HAZOP:  Analyzes operational hazards  Prevents costly recalls and shortages.
  • 30.
    Supply Chain Risks Raw material shortages.  Transportation delays.  Affects market availability.
  • 31.
    Production Failure Risks Equipment malfunction.  Quality defects.  Leads to recalls and brand damage.
  • 32.
    Business Continuity Planning Emergency preparedness strategies.  Backup suppliers and facilities.  Ensures uninterrupted market supply
  • 33.
    Integrated Marketing Impact Packaging + Safety + Risk management.  Builds trust and loyalty.  Strengthens competitive position.
  • 34.
    Conclusion  Strategic managementsupports marketing success.  Protects brand image.  Ensures sustainable pharmaceutical growth.

Editor's Notes

  • #8 Packaging acts as a silent salesman in pharmaceutical marketing. It communicates quality, safety, and professionalism without words. Attractive and well-designed packaging improves brand recognition and increases confidence among doctors and patients.”
  • #9 Primary packaging comes in direct contact with the drug, such as blister packs, bottles, and ampoules. Its main function is to protect the product and maintain stability. From a marketing point of view, good primary packaging improves patient convenience and adherence, which builds brand loyalty.”
  • #10 “Secondary packaging includes cartons and package inserts. It provides protection and essential information about the medicine. Marketing-wise, it supports branding, visual identity, and professional appearance, which influences prescription behavior.”
  • #11 “Tertiary packaging is used for bulk storage and transportation. Although patients do not see it, it plays an important role in ensuring product availability in the market. Efficient tertiary packaging reduces supply disruptions and supports consistent market presence.”
  • #12 “Tertiary packaging is used for bulk storage and transportation. Although patients do not see it, it plays an important role in ensuring product availability in the market. Efficient tertiary packaging reduces supply disruptions and supports consistent market presence.”
  • #13 Patient-friendly packaging improves correct dosing and adherence to therapy. Unit-dose and easy-to-open packaging help patients follow treatment properly. Better compliance results in improved outcomes and stronger brand loyalty.
  • #14 “In competitive markets, packaging helps differentiate one brand from another. Design, color, and layout increase shelf visibility and brand recall. Thus, packaging supports competitive pharmaceutical marketing strategies.”
  • #15 Packaging decisions depend on the target market. Premium brands use advanced packaging, while generics focus on cost-effectiveness. This shows how packaging supports market segmentation and pricing strategies.”